BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36801152)

  • 1. An update on genetic aberrations in T-cell neoplasms.
    Parilla M; Quesada AE; Medeiros LJ; Thakral B
    Pathology; 2023 Apr; 55(3):287-301. PubMed ID: 36801152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into the pathogenesis of T-cell lymphomas.
    Van Arnam JS; Lim MS; Elenitoba-Johnson KSJ
    Blood; 2018 May; 131(21):2320-2330. PubMed ID: 29666117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
    Boulton E; Cleary H; Plumb M
    Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification of lymphomas].
    Molina T; Diebold J; Audouin J
    Rev Prat; 2002 May; 52(9):951-8. PubMed ID: 12063760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-cytometric analysis of lymphocytes, leukaemias and lymphomas.
    Macey MG
    Br J Biomed Sci; 1993 Dec; 50(4):334-49. PubMed ID: 8130695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenotypes of lymphoid malignancies; the rearrangement of T cell receptor beta chain gene can occur before the gamma chain gene rearrangement.
    Miwa H; Nosaka T; Kita K; Ohno T; Matsuoka N; Shirakawa S; Arita Y; Doi S; Nishikori M; Honjo T
    Jpn J Cancer Res; 1988 Apr; 79(4):484-90. PubMed ID: 3133337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathology of the chronic lymphoid leukaemias.
    Kroft SH; Finn WG; Peterson LC
    Blood Rev; 1995 Dec; 9(4):234-50. PubMed ID: 8839399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
    Bailey NG; Elenitoba-Johnson KSJ
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31932467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells.
    Boi M; Stathis A; Zucca E; Inghirami G; Bertoni F
    Cancer Sci; 2012 Aug; 103(8):1397-404. PubMed ID: 22568409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology.
    Kluin PM; Feller A; Gaulard P; Jaffe ES; Meijer CJ; Müller-Hermelink HK; Pileri S
    Histopathology; 2001 Mar; 38(3):250-70. PubMed ID: 11260307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetics of lymphomas.
    Campbell LJ
    Pathology; 2005 Dec; 37(6):493-507. PubMed ID: 16373229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders.
    O'Connor NT; Wainscoat JS; Weatherall DJ; Gatter KC; Feller AC; Isaacson P; Jones D; Lennert K; Pallesen G; Ramsey A
    Lancet; 1985 Jun; 1(8441):1295-7. PubMed ID: 2860492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.
    Oschlies I; King RL; Dotlic S; Montes-Moreno S; Ponzoni M; Traverse-Glehen A; Calaminici M; Ferry JA; Ott G; Goodlad JR
    Virchows Arch; 2020 May; 476(5):683-699. PubMed ID: 31781845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of malignant lymphomas.
    Harris NL
    Curr Opin Oncol; 1991 Oct; 3(5):813-21. PubMed ID: 1661168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding intraocular lymphomas.
    Coupland SE; Damato B
    Clin Exp Ophthalmol; 2008 Aug; 36(6):564-78. PubMed ID: 18954321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.